Glucagon Definition and Market Trends: Multi-Peptide Product Composition, Brand Comparison, and Industry Data Analysis
Glucagon Definition and Market Trends: Multi-Peptide Product Composition, Brand Comparison, and Industry Data Analysis Glucagon, a 29-amino-acid peptide hormone, is critical for glucose homeostasis. The multi-peptide product market is expanding at a CAGR of 8.5% (2024-2030), driven by metabolic and anti-aging applications. Leading brands (e.g., Novo Nordisk, Eli Lilly) dominate via patented formulations, while generics offer cost advantages. Key technical parameters include purity (>98%), stability, and bioactivity. Product certifications (GMP, ISO 9001) ensure quality. Selection criteria prioritize supplier audits, cold-chain logistics (2-8°C), and batch consistency. Industry data reveals rising demand for dual-agonist peptides (GIP/GLP-1). Future trends focus on oral delivery and personalized peptide therapies.